Psychiatr. praxi. 2014;15(1):15-18

Mild cognitive impairment - Do we know more now?

MUDr.František Honzák1,2
1 Psychiatrická nemocnice v Kroměříži
2 Lékařská fakulta UP v Olomouci

Mild cognitive impairment is heterogenous entity comprising both subjective and objektive impairment of at lest one of cognitive functions.

Mild cognitive impairment is pathological condition, which is no more normal, but still not fulfilling kriteria for dementia. Review

describes historical context of terminology, basic diagnostic kriteria for mild cognitive impairment, differential diagnostics and outskirt

of therapeutic modalities of mild cognitive impairment.

Keywords: mild cognitive impairment, cognitive spectrum, cognitive functions, diagnostic kriteria, treatment of mild cognitive impairment

Published: March 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Honzák F. Mild cognitive impairment - Do we know more now? Psychiatr. praxi. 2014;15(1):15-18.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Sheardová K. Mírná kognitivní porucha v praxi. Psychiatr pro Praxi 2010; 11(2): 62-65.
    2. Hort J, Jirák R. Alzheimerova choroba a jiné demence aneb co v učebnicích 20. století nebylo. Praha: MediMedia Information 2007; 32 s.
    3. Hort J, Rusina R, a kol. Paměť a její poruchy. Paměť z hlediska neurovědního a klinického. Praha: Jessenius Maxdorf 2007; 422 s.
    4. Vyhnálek M, Bartoš A, Dostál V, et al. Diagnostikujeme demence správně a včas? Výsledky průzkumu ve světle nových doporučení. Psychiatr pro Praxi 2012; 13(1): 19-24.
    5. Čechová L, Bartoš A, Doležil D, a kol. Alzheimerova nemoc a mírná kognitivní porucha: diagnostika a léčba. Neurol. Praxi 2011; 12(3): 175-180.
    6. Martínek P, Bartoš A. Použití dotazníků aktivit denního života u pacientů s Alzheimerovou nemocí. Cesk Slov Neurol N 2011; 74/107(6): 632-640.
    7. Lesley JR, Victoria BC. Mild cognitive impairment: case definitions, age and other risk factors. [on line]. Dostupné z: http://cirrie.buffalo.edu/encyclopedia/en/article/117/[citováno27.08.2013].
    8. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Int Med 2004; 256: 183-194. Go to original source... Go to PubMed...
    9. Albert M, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer´s disease: Recommendations from the National Institute on Aging-Alzheimer´s Association workgroups on diagnostic guidelines for Alzheimer´s disease. Alzheimer´s Dementia 2011; 7: 270-279. Go to original source... Go to PubMed...
    10. Petersen RC. Mild cognitive impairment: where we are? Alzheimer Dis Assoc Disord. 2005; 19(3): 166-169. Go to original source... Go to PubMed...
    11. Lo RY, Hubbard AE, Shaw LM, et al. Longitudinal change of biomarkers in cognitive decline. Arch Neurol. 2011; 68(10): 1257-1266. Go to original source... Go to PubMed...
    12. Fleischer AS, Sowell BB, Taylor C, Gamst AC, Petersen RC, Thal LJ, et al. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology 2007; 68(19): 1588-1595. Go to original source... Go to PubMed...
    13. Fleischer AS, Sun S, Taylor C, Ward CP, Gamst AC, Petersen RC, et al. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment.Neurology 2008 Jan 15; 70(3): 191-199. Go to original source... Go to PubMed...
    14. Jauhiainen AM, Pihlajamaki M, Tervo S, Niskanen E, Tanila H, Hanninen T, et al. Discriminating accuracy of medial temporal lobe volumetry and fMRI in mild cognitive impairment. Hippocampus 2009; 19(2): 166-175. Go to original source... Go to PubMed...
    15. Devenand DP, Pradhaban G, Liu X, Khandji A, De Santi S, Segal S, et al. Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology 2007; 68(11): 828-836. Go to original source... Go to PubMed...
    16. Devenand DP, Pelton GH, Zamora D, Liu X, Tabert MH, Goodkind M, et al. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment. Arch Neurol 2005; 62(6): 975-980. Go to original source... Go to PubMed...
    17. Lužný J. Gerontopsychiatrie. Praha: Triton; 159 s.
    18. Lužný J, Ivanová K. Hypothyreoidism in seniors hospitalized in inpatient psychogeriatric wards in Mental hospital in Kroměříž. Scripta Medica, 2010; 1(1): 69-71.
    19. Lužný J, Bellová J, Doněk E. Does gerontopsychiatry belong to medicine? Cross sectional study monitoring polymorbidity in hospitalized gerontopsychiatric patients. Biomed Pap Med Fac Univ Palacky Czech Repub, 2010; 154(1): 89-92. Go to original source... Go to PubMed...
    20. Tariska P, Paksy A. Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia. Orv Hetil. 2000; 141(22): 1189-1193. Go to PubMed...
    21. Bettermann K, Arnold AM, Williamson J, Rapp S, Sink K, Toole JF, et al. J Statins, risk of dementia, and cognitive function: secondary analysis of the ginkgo evaluation of memory study. Stroke Cerebrovasc Dis 2012; 21(6): 436-444. Go to original source... Go to PubMed...
    22. Lužný J, Ivanová K. Je ještě možné zlepšit kvalitu života těchto seniorů? Vojenské zdravotnické listy, 2010; 79(3): 96-104.
    23. Lužný J, Ivanová K. Quality of life in hospitalized seniors with psychiatric disorders. Biomed Pap Med Fac Univ Palacky Czech Repub. 2009; 153(4): 1-4. Go to original source... Go to PubMed...
    24. Snitz BE, O´Meara ES, Carlson MC, Arnold AM, Ives DG, Rapp SR, et al. Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. JAMA. 2009; 302(24): 2663-2670. Go to original source... Go to PubMed...
    25. Birks J, Grimley EV, Van Dongen M. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev 2002; (4): CD003120. Go to original source...
    26. Petersen RC, Thomas RG, Grindman M, Benent D, Doody R, Ferris S, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005; 352(23): 2379-2388. Go to original source... Go to PubMed...
    27. Blacker D. Mild cognitive impairment-no benefit from vitamin E, little from donepezil. N Engl J Med. 2005; 352(23): 2439-2441. Go to original source... Go to PubMed...
    28. Barnes DE, Yaffe K, Belfor N, Jagust WJ, DeCarli C, Reed BR, Kramer JH. Computer-based cognitive training for mild cognitive impairment: results from a pilot randomized, controlled trial. Alzheimer Dis Assoc Disord. 2009; 23(3): 205-210. Go to original source... Go to PubMed...
    29. Kirschner HS. Mild cognitive impairment: to treat or not to treat. Curr Neurol Neurosci Rep. 2005; 5(6): 455-457. Go to original source... Go to PubMed...
    30. Gold M, Newhouse PA, Howard D, Kryscio RJ. Nicotine treatment of mild cognitive impairment: a 6-month double-blind pilot clinical trial. Neurology 2012; 78(23): 1895. Go to original source... Go to PubMed...
    31. Roh S, Evins AE. Possible role of nicotine for the treatment of mild cognitive impairment. Expert Rev Neurother 2012; 12(5): 531-533. Go to original source... Go to PubMed...
    32. Buschert VC, Friese U, Teipel SJ, Schneider P, Merensky W, Rusjescu D, et al. Effects of a newly developed cognitive intervention in amnestic mild cognitive impairment and mild Alzheimer's disease: a pilot study. Alzheimers Dis. 2011; 25(4): 679-694. Go to original source... Go to PubMed...
    33. Buschert VC, Giegling I, Teipel SJ, Jolk S, Hampel H, Rujescu D, et al. Long-term observation of a multicomponent cognitive intervention in mild cognitive impairment. J Clin Psychiatry 2012; 73(12): e1492-1498. Go to original source... Go to PubMed...
    34. Lužný J. Nefarmakologické ovlivnění kognitivních funkcí u klientů s demencí. Ošetřovatelství a porodní asistence, 2011; 2(4): 312-318.
    35. Lužný J, Skopalová B. Kognitivní remediace u mírné kognitivní poruchy. Psychiatr. Prax, 2013; 14(4) Go to PubMed...

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.